Note: All links within
content go to MayoClinic.com
Diseases and Conditions
Viral hemorrhagic fevers
From MayoClinic.com
Special to CNN.com Overview In 1995, Ebola, an especially gruesome and fatal disease, killed hundreds of people in the Democratic Republic of Congo. Ten years later, hundreds more died in Angola of Marburg virus, an equally deadly illness. But for all their notoriety, Ebola and Marburg virus are only two of a group of related illnesses called viral hemorrhagic fevers (VHFs), some of which pose a far greater threat to your health. Viral hemorrhagic fevers are caused by viruses from four distinct families and range in severity from relatively mild to life-threatening. Although all begin with fever and muscle aches, some viral hemorrhagic fevers progress to far more serious problems, including severe internal and external bleeding (hemorrhage), widespread tissue death (necrosis), and shock. The origin of Ebola and Marburg viruses isn't known, but the viruses that cause other hemorrhagic fevers are transmitted to humans by animals or insects. In some but not all cases, viral hemorrhagic fevers can then spread from person to person through contact with infected blood or body fluids, including semen. Secondary transmission can also occur through contaminated needles and syringes, a particular problem in developing nations where medical equipment is in short supply and may be reused. No current treatment can cure viral hemorrhagic fevers, and immunizations exist for only two of the many VHFs. Researchers are working to develop other vaccines, but in the meantime, the best approach is prevention. Signs and symptoms The VHF designation includes a broad range of diseases, and signs and symptoms can vary widely, even among members of the same viral family. But VHFs do have some common characteristics, especially their effect on your vascular system — the network of arteries, veins and capillaries that circulates blood throughout your body. Hemorrhagic fevers make blood vessels more permeable — that is, more likely to leak — causing bleeding that can range from relatively minor to massive. Bleeding may occur under the skin, in internal organs, and from the mouth, eyes, ears and rectum. People with severe bleeding may experience potentially lethal symptoms such as shock and coma, but rarely die of blood loss. In general, signs and symptoms of most VHFs begin two days to three weeks after you've been exposed to the virus. All begin with fever and muscle aches; many cause vomiting and diarrhea; and all create problems in a number of organ systems, especially your liver, lymphatic system, lungs and sometimes your kidneys. Problems more specific to diseases within each of the four families of viruses that cause VHFs are listed below. Arenaviruses
Bunyaviruses
Filoviruses
Depending on the strain, Ebola and Marburg viruses are fatal in 50 percent to 90 percent of infected people and are almost always fatal in pregnant women. Flaviviruses Signs and symptoms of dengue fever vary with age. Infants and young children usually develop a rash and severe, flu-like symptoms, whereas older children and adults may experience a high fever, severe headache, eye pain, muscle aches and rash. In the hemorrhagic form, an extremely high fever may be accompanied by bleeding, convulsions and circulatory failure. Both Kyasanur Forest disease and Omsk hemorrhagic fever are biphasic diseases, meaning that the initial signs and symptoms are followed by a brief period of recovery before symptoms reappear. No matter when they occur, signs and symptoms of these two diseases generally include:
Causes Emerging diseases are infections that are appearing for the first time or that are rapidly increasing in incidence and range. Many of these infections have surfaced in the past several decades, including VHFs such as Ebola and hantavirus pulmonary syndrome and illnesses such as HIV/AIDS, Lyme disease and SARS. Although emerging diseases often seem to have materialized out of thin air, they usually occur because environmental and demographic changes bring already existing germs and humans together. These changes don't occur in isolation, but rather work together in a complex series of interactions. The emergence of hantavirus pulmonary syndrome in the southwestern United States in 1993 is a case in point. The virus that causes hantavirus pulmonary syndrome (Sin Nombre virus, meaning "No Name virus" in Spanish) spreads to humans through contact with the infected droppings, urine or saliva of deer mice. It's likely that mice in the Four Corners region — an area shared by Colorado, New Mexico, Arizona and Utah where the syndrome first appeared — have carried the virus for hundreds, perhaps thousands, of years. But in 1993, a particular confluence of factors created conditions that allowed the virus to spread to people. The most important of those factors was a dramatic rise in the mouse population, which burgeoned in 1993 — an unusually mild and rainy year that followed a long drought. Researchers at the Centers for Disease Control and Prevention reported a tenfold increase in mice in the Four Corners area between 1992 and 1993 alone. But not only did the weather bring more mice into contact with people, it also brought more people into contact with mice. Like the rodent population, the human population had grown: The area was popular with hikers and campers, and more and more vacationers were building second homes in the area. The combination of a large number of infected animals, an increasing number of people and a shrinking habitat is likely to have led to the emergence of a new disease, though one that in all probability was new in name only. Still, the origins of all emerging disease aren't quite as clear-cut. No one, for instance, yet knows the source of Ebola or of Marburg virus, a slightly less lethal version of Ebola. Although nonhuman primates such as monkeys, chimpanzees and gorillas are susceptible to these diseases and can transmit them to humans, scientists don't think that they're the original source of infection (natural reservoir). Whatever the natural reservoir, it's likely to have harbored the Ebola virus for some time. It's also likely that the virus would have remained hidden had humans not inadvertently come in contact with it. Human activity is often responsible for the abrupt appearance of a supposedly "new" pathogen. When people alter or encroach on native habitat, especially habitat that's still relatively biodiverse, the stage is set for an emerging disease. Combine this with the mobility and interconnectedness of the modern world, and it becomes clear how an infection that once might have remained isolated in an obscure village can become a worldwide epidemic — sometimes in an astonishingly short period of time. The rapid spread of SARS is a notable example of just how quickly a local illness can become a global problem. What, where, when and how Arenaviruses
Argentine, Bolivian, Brazilian and Venezuelan hemorrhagic fevers are less pervasive illnesses occurring only in South America. All are carried by rodents. The Bolivian type can also be transmitted from person to person. Bunyaviruses
Filoviruses
Flaviviruses
Risk factors The chance of contracting most VHFs is low. Some are confined to isolated pockets in remote areas where the risk of transmission is slight. And because each virus is usually associated with a specific host species, it's normally restricted to the area where that species lives. Yet taken together, the viruses that cause VHFs occur over most of the world. And some VHFs, especially Lassa, yellow and dengue hemorrhagic fevers, pose a real threat to people traveling to or living in regions where these diseases are widespread, primarily sub-Saharan Africa and South America. In general, your risk of contracting any disease abroad depends on your itinerary and activities, the length of your stay and the rate of transmission of a particular disease at the time. If you're visiting a region for a week or two, staying in westernized hotels and taking guided tours, your risk is less than if you're traveling for months and living in a tent. Still, you're at risk of epidemic diseases such as dengue fever even in the best of circumstances, although your risk decreases if there are no outbreaks of the disease during your visit. In the United States, you're more likely to contract a hantavirus if your region has a large rodent population known to carry the virus. The risk increases if you live in the country or suburbs, you work outdoors, or you spend time in rodent-infested buildings. Still, the risk is generally low. As of May 2006, slightly more than 400 cases of hantavirus pulmonary syndrome had been reported in the United States since 1993. Most occurred in states west of the Mississippi. On the other hand, hospital workers treating people with VHFs as well as researchers and laboratory personnel who deal with the viruses are at high risk of infection. In Africa, health care workers frequently contract Ebola from patients, and a number of cases of laboratory-acquired infection have been documented worldwide. When to seek medical advice See a doctor immediately if you suspect you've been exposed to a VHF virus. If you become ill while traveling in a foreign country, call the U.S. Consulate for a list of doctors. Better yet, find out in advance about medical care in the areas you'll visit, and carry a list of the names, addresses and phone numbers of recommended English-speaking doctors. Your doctor, local or state medical society, the International Association for Medical Assistance to Travellers or the Department of State's Office of Overseas Citizens Services can help provide the information you need. In addition, many experts strongly advise purchasing medical evacuation insurance before you travel. If you develop signs and symptoms once you return home, consider consulting a doctor who focuses on international medicine or infectious diseases. A specialist may be able to recognize and treat your illness more quickly than a doctor who isn't trained in these areas can. Screening and diagnosis Diagnosing specific VHFs in the first few days of illness can be difficult. All infected people initially exhibit the same signs and symptoms: fever, muscle aches, headache and extreme fatigue. What's more, these signs and symptoms frequently occur with many diseases that are far more common than VHFs. To reach an accurate diagnosis, your doctor is likely to ask about your medical and travel history and any exposure to rodents or mosquitoes. Be sure to describe international trips in detail, including the countries you visited and the dates, as well as any contact you may have had with possible sources of infection. Laboratory tests, usually using a sample of your blood, are needed to confirm a diagnosis of VHF. Because VHF viruses are particularly virulent and contagious, these tests are usually performed in specially designated laboratories using strict precautions. Complications Although complications of VHFs vary, some problems occur with many of the viruses. They include:
Treatment No specific treatment exists for most VHFs, although the antiviral drug ribavirin may help shorten the course of infection and prevent complications in arenaviruses and bunyaviruses. Whether bleeding complications should be treated with therapies such as clotting factors, platelets and heparin remains a matter of debate. Supportive care is essential for every person with VHF, no matter what type of virus is involved. This is likely to include measures to:
Prevention Preventing VHFs, especially in developing nations, presents enormous challenges. Many of the social, economic and ecological factors that contribute to the sudden appearance and spread of infectious diseases — war, displacement, destruction of habitat, lack of sanitation and proper medical care — are problems that have no easy or quick solutions. For that reason, the best approach in the short-term is to take precautions to protect yourself from infection:
At home
August 15, 2006 |